Goaded By Tariffs, European Pharmaceutical Industry Pivots To The US Authored by Evgenia Filimianova via The Epoch Times, The U.S. tariff policy and its unmatched pharmaceutical market are pulling European drugmakers to invest more heavily, from new manufacturing plants to U.S. stock listings and di......